Patent application number | Description | Published |
20090118887 | METHOD FOR CONTROLLING REGENERATIVE BRAKING AND FRICTION BRAKING - A vehicle includes a powertrain system and a friction braking system communicating tractive torque with a driveline, the powertrain system including a torque machine, and an energy storage device connected to the torque machine, said torque machine communicating tractive torque with the driveline. A method for controlling regenerative braking and friction braking includes monitoring a vehicle operating point, determining a braking torque request, determining a regenerative braking motor torque ratio based upon the vehicle operating point wherein the regenerative braking motor torque ratio is non-linearly dependent on the vehicle operating point, and actuating the friction brake based upon the regenerative braking motor torque ratio and the braking torque request. | 05-07-2009 |
20090118888 | METHOD FOR CONTROLLING REGENERATIVE BRAKING IN A VEHICLE - A vehicle includes a friction braking system and a powertrain system including a torque machine operative to react tractive torque input from a wheel of the vehicle. A method for controlling braking in a vehicle includes monitoring operation of the powertrain system, determining a driver intended total brake torque, determining a regenerative braking capacity based upon the operation of the powertrain system, determining a regenerative braking request based upon a time-rate change in the regenerative braking capacity, and determining a motor torque command for the torque machine based upon the regenerative braking request. | 05-07-2009 |
20100217464 | DYNAMIC HYSTERESIS EVALUATION METHOD FOR HYBRID VEHICLES BASED ON OPTIMAL POWER LOSS CONTROL STRATEGY - A hybrid control system comprises a power loss (PL) determination module, a hysteresis estimation module, and a mode determination module. The PL determination module determines a power loss of a hybrid drivetrain based on an engine speed, a motor speed, and a vehicle speed. The hysteresis estimation module determines an average power loss of the hybrid drivetrain based on the power loss and determines a hysteresis power loss of the hybrid drivetrain based on the average power loss. The mode determination module selects an operation mode of the hybrid drivetrain based on the hysteresis power loss. The hybrid control system controls the hybrid drivetrain based on the operation mode. | 08-26-2010 |
Patent application number | Description | Published |
20080248393 | TIN IN AN ACTIVE SUPPORT MATRIX - An anode material made from nanoparticles, said anode material including a homogeneous mixture of lithium-alloying nanoparticles with active support matrix nanoparticles, is provided. The active support matrix nanoparticle is a compound that participates in the conversion reaction of the lithium battery. The compound is preferably a transition metal compound, with said compound including a nitride, carbide, oxide or combination thereof. | 10-09-2008 |
20090179181 | SILICON BASED COMPOSITE MATERIAL - A composite material having utility as an anode for lithium ion batteries comprises silicon, a transition metal, a ceramic and an electrically conductive diluent such as carbon. In particular instances, the ceramic is electrically conductive, and may comprise vanadium carbide or tungsten carbide. The transition metal may, in some instances, comprise iron. The material may be fabricated by grinding together a starting mixture of the components, and grinding may be accomplished in a high impact ball milling process, and the grinding step may cause partial alloying of the silicon with the metal and/or carbon. Further disclosed is a method for making the material as well as electrodes which incorporate the material. | 07-16-2009 |
20090186277 | MIXED METAL OLIVINE ELECTRODE MATERIALS FOR LITHIUM ION BATTERIES - A positive electrode material is provided including an electroactive material having one or more phases comprising lithium (Li), an electroactive metal (M), and phosphate (PO | 07-23-2009 |
20110014102 | MATERIALS AND METHODS FOR THE REMOVAL OF SULFUR COMPOUNDS FROM FEEDSTOCK - A composite material having utility for removing sulfur from a feedstock comprises a ceramic matrix having a relatively low melting point metal such as tin, zinc, lead or bismuth nanodispersed therein. The material may be prepared from a mixture of particles of a precursor of the ceramic matrix and precursor of the metal. The precursors are selected such that the melting point of the precursor of the ceramic is less than the melting point of the precursor of the metal. The mixture of precursor materials is heated to a temperature sufficient to melt the precursor of the ceramic material so as to coat it onto the precursor of the metal. The ceramic precursor is then reacted so as to convert it to a ceramic. Thereafter, the precursor of the metal is converted to a free metal which is retained within the ceramic matrix so as to prevent agglomeration. | 01-20-2011 |
20110068295 | FERRIC PHOSPHATE AND METHODS OF PREPARATION THEREOF - High-purity crystalline ferric phosphate material with desirable characteristics for use in synthesis of nano-sized LFP cathode material are described. The ferric phosphate dihydrate material has as disclosed herein has a molar ratio of phosphorous to iron is from about 1.001 to about 1.05, a surface area of from about 25 m | 03-24-2011 |
20140255785 | SILICON-GRAPHENE NANOCOMPOSITES FOR ELECTROCHEMICAL APPLICATIONS - A nanographitic composite for use as an anode in a lithium ion battery includes nanoscale particles of an electroactive material; and a plurality of graphene nanoplatelets having a thickness of 0.34 nm to 5 nm and lateral dimensions of less than 900 nm, wherein the electroactive particle has an average particle size that is larger than the average lateral dimension of the graphene nanoplatelets, and the graphene nanoplatelets coat at least a portion of the nanoscale particles to form a porous nanographitic layer made up of overlapping graphene nanoplatelets. | 09-11-2014 |
Patent application number | Description | Published |
20100203139 | NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME - The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a | 08-12-2010 |
20150216826 | NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME - The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a | 08-06-2015 |
20150273025 | APYRASE TREATMENTS - Provided herein is technology relating to compositions comprising apyrase and particularly, but not exclusively, to compositions comprising apyrase, methods of treating with apyrase, and uses of apyrase related to treating a subject, e.g., a subject suffering from a microbial infection, a subject who has a wound or burn and is in need of an antimicrobial treatment, and/or a subject in need of treatment for heterotopic ossification. | 10-01-2015 |
Patent application number | Description | Published |
20100061929 | NEOPLASIA TARGETING PEPTIDES AND METHODS OF USING THE SAME - The present invention provides compositions including neoplasia targeting peptides as well as methods of using the neoplasia targeting peptides in diagnosing, detecting, treating, monitoring treatment, and analyzing cancer or cancer cells in vivo and in vitro. | 03-11-2010 |
20100310459 | Targeted Detection of Dysplasia In Barrett's Esophagus With A Novel Fluorescence-Labeled Polypeptide - The present invention is directed to compositions and methods for use in detecting dysplasia in Barrett's esophagus. | 12-09-2010 |
20110125029 | Targeted Dual-Axes Confocal Imaging Apparatus with Vertical Scanning Capabilities - An optical device is described that may be used as a microscope system for real-time, three-dimensional optical imaging. The device includes a miniature, fiber optic, intra-vital probe microscope that uses a dual-axes confocal architecture to allow for vertical scanning perpendicular to a surface of the sample (e.g., a tissue surface). The optical device can use off-axis illumination and collection of light to achieve sub-cellular resolution with deep tissue penetration. The optical device may be used as part of an integrated molecular imaging strategy using fluorescence-labeled peptides to detect cell surface targets that are up-regulated by the epithelium and/or endothelium of colon and breast tumors in small animal models of cancer. | 05-26-2011 |
20120219505 | PEPTIDE REAGENTS AND METHODS FOR DETECTION OF COLON DYSPLASIA - The present invention is directed to peptide reagents, methods for detecting colon pre-cancer (dysplasia with non-polypoid or polypoid morphology) or cancer using the peptide reagents, and methods for targeting pre-cancerous or cancerous colon cells using the peptide reagents. | 08-30-2012 |
20120270256 | Two-Photon Endoscopic Scanning Assembly for Inflammatory Disease Detection - An endscopic imaging device is described that achieves longitudinal axis (z-axis) scanning into a tissue or sample, using a piezoelectric microactuator. In some configurations, additional lateral (xy-plane) scanning is also achieved, to allow for the creation of full three-dimensional imaging, ex vivo or in vivo. The techniques may be used to image and diagnosis allergic rhinitis and eosinophilic esophagitis in tissue. | 10-25-2012 |
20140255985 | TWO-PHOTON ENDOSCOPIC SCANNING ASSEMBLY FOR INFLAMMATORY DISEASE DETECTION - An endscopic imaging device is described that achieves longitudinal axis (z-axis) scanning into a tissue or sample, using a piezoelectric microactuator. In some configurations, additional lateral (xy-plane) scanning is also achieved, to allow for the creation of full three-dimensional imaging, ex vivo or in vivo. The techniques may be used to image and diagnosis allergic rhinitis and eosinophilic esophagitis in tissue. | 09-11-2014 |
Patent application number | Description | Published |
20100009382 | METHODS AND COMPOSITIONS FOR DIAGNOSING LUNG CANCER - The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ubiquilin 1 markers for cancer. | 01-14-2010 |
20110070652 | PHAGE MICROARRAY PROFILING OF THE HUMORAL RESPONSE TO DISEASE - The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers. | 03-24-2011 |
20110207675 | GENE FUSION TARGETED THERAPY - The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer. | 08-25-2011 |
20110237461 | USING PHAGE EPITOPES TO PROFILE THE IMMUNE RESPONSE - The present disclosure provides compositions and methods for using one or more polypeptide probes to profile an immune response. The polypeptide probe can be used to detect one or more antibodies from a sample. Furthermore, the present disclosure provides methods and compositions for characterizing a cancer based on the detection of one or more antibodies, such as autoantibodies. | 09-29-2011 |
20160041174 | USING PHAGE EPITOPES TO PROFILE THE IMMUNE RESPONSE - The present disclosure provides compositions and methods for using one or more polypeptide probes to profile an immune response. The polypeptide probe can be used to detect one or more antibodies from a sample. Furthermore, the present disclosure provides methods and compositions for characterizing a cancer based on the detection of one or more antibodies, such as autoantibodies. | 02-11-2016 |
Patent application number | Description | Published |
20090325868 | Materials And Methods For FOXP3 Tumor Suppression - Provided herein are methods of treating a cancer in a subject comprising administering a FOXP3 protein, a nucleic acid encoding a FOXP3 protein, or an inducing compound which induces FOXP3 protein expression. Methods of altering a phenotype of a cancer cell or tumor cell, methods of inhibiting growth of such cells, and methods of inducing apoptosis of these cells are also provided herein. These methods comprise contacting the cell with a FOXP3 protein, a nucleic acid encoding a FOXP3 protein, or an inducing compound which induces FOXP3 protein expression. Further provided herein are diagnostic methods, comprising comparing the expression or structure of a FOXP3 protein or FOXP3 gene in a test sample to that of a normal or prior sample. A method of screening a test compound for anti-cancer activity comprising administering to cells the test compound and measuring FOXP3 protein or FOXP3 gene expression is moreover provided herein. | 12-31-2009 |
20110126219 | Middleware for Extracting Aggregation Statistics to Enable Light-Weight Management Planners - Management of a planner through use of a middleware layer. A computer system is configured with the middleware layer in communication with both a planner and a data repository. One or more modules are provided in the middleware layer to support the functionality of the planner. Application program interface calls are employed to call the modules, thereby mitigating duplication of the functionality in separate planners. | 05-26-2011 |
20120264697 | USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS - The present invention relates to treating a hematologic cancer using a Hypoxia- Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor. | 10-18-2012 |
Patent application number | Description | Published |
20090118528 | NATURAL GAS DESULFURIZATION - A method for desulfurizing natural gas includes contacting the natural gas with an adsorbent which preferentially adsorbs at least one of hydrogen sulfide, COS, sulfur odorants, or combinations thereof, at a selected temperature and pressure, thereby producing desulfurized natural gas and an at least one of hydrogen sulfide/COS/sulfur odorant/combinations thereof-rich adsorbed component. The adsorbent includes a copper species adapted to form π-complexation bonds and direct metal-sulfur bonds with the at least one of hydrogen sulfide, COS, sulfur odorants, or combinations thereof, and wherein the preferential adsorption occurs by π-complexation and direct metal-sulfur bonding. | 05-07-2009 |
20130045867 | METAL SALT CATALYSTS FOR ENHANCING HYDROGEN SPILLOVER - A composition for hydrogen storage includes a receptor, a hydrogen dissociating metal doped on the receptor, and a metal salt doped on the receptor. The hydrogen dissociating metal is configured to spill over hydrogen to the receptor, and the metal salt is configured to increase a rate of the spill over of the hydrogen to the receptor. | 02-21-2013 |